US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 30.960
  • -0.130-0.42%
Close Feb 28 16:00 ET
  • 30.950
  • -0.010-0.03%
Post 19:59 ET
11.94BMarket Cap-3.34P/E (TTM)

About Moderna Company

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolMRNA
Company NameModerna
Listing DateDec 7, 2018
Issue Price23.00
Founded2010
CEOMr. Stephane Bancel
MarketNASDAQ
Employees5800
Fiscal Year Ends12-31
Address325 Binney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-714-6500
Websitehttp://www.modernatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephane Bancel
  • Director and Chief Executive Officer
  • 17.07M
  • Kate Cronin
  • Chief Brand Officer
  • --
  • Tracey Franklin
  • Chief Human Resources Officer
  • --
  • Shannon Thyme Klinger
  • Chief Legal Officer and Corporate Secretary
  • 4.31M
  • Brad Miller
  • Chief Information Officer
  • --
  • Jerh Collins
  • Chief Technical Operations and Quality Officer
  • --
  • James M Mock
  • Chief Financial Officer and Principal Accounting Officer
  • 4.32M
  • Dr. Noubar B. Afeyan, PhD
  • Chairman of the Board
  • 663.52K
  • Dr. Stephen Hoge, M.D.
  • President
  • 7.34M
  • Abbas Hussain
  • Director
  • --
  • David M. Rubenstein
  • Director
  • --
  • Dr. Francois Nader, M.D.
  • Independent Director
  • 481.27K
  • Elizabeth E. Tallett
  • Independent Director
  • 481.27K
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 481.27K
  • Dr. Elizabeth G. Nabel, M.D.
  • Independent Director
  • 476.25K
  • Paul Sagan
  • Independent Director
  • 461.27K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!